Report Detail
Global (United States, European Union and China) Anti Microbial Peptides Market Research Report 2019-2025
- RnM3653606 |
- 07 August, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
Global anti-microbial peptides market is segmented on the basis of peptides types such as plant anti-microbial peptides, bacterial anti-microbial peptides, animal anti-microbial peptides, insect anti-microbial peptides. Among these segments, animal and plant anti-microbial peptides are capturing the major share into the market as they are easy to extract as compared with other anti-microbial peptides. Researchers are also more inclined towards animal and plant anti-microbial peptides to observe and check under clinical trials.
Europe and North America are the leading regions in global anti-microbial peptide market owing to the large investment in R&D and healthcare industry. Europe anti-microbial peptides market valued USD 0.39 billion in 2016, and is projected to grow at a CAGR of 9.0% during the forecast period. There are approximately 45 peptides which are approved globally and are being used in different verticals out of which 5-6 are from Europe. European Union has announced to invest USD 1.7 billion to develop antimicrobial peptide drugs to tackle against drug-resistant bacteria. Europe was marketed for nearly 110 peptides in clinical trials and more than 150 peptides in advanced pre-clinical phase. Germany and the UK hold the major share of antimicrobial peptides market. Moreover, Greece is the largest and only producer of generic peptides of European Union.
In 2019, the market size of Anti Microbial Peptides is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti Microbial Peptides.
This report studies the global market size of Anti Microbial Peptides, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti Microbial Peptides sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AnaSpec
Novozymes
Bachem
Phoenix Biotech
AMP Biotech
Shanghai Abbiochem Company
Ramamoorthy Group
Lytix Biopharma
Ai2
Market Segment by Product Type
Plant Anti-Microbial Peptides
Bacterial Anti-Microbial Peptides
Animal Anti-Microbial Peptides
Insects Anti-Microbial Peptides
Market Segment by Application
Personal Care and Cosmetics Industry
Healthcare & Pharmaceuticals Industry
Biotechnology Industry
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti Microbial Peptides status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti Microbial Peptides manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti Microbial Peptides are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anti Microbial Peptides Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Plant Anti-Microbial Peptides
- 1.3.3 Bacterial Anti-Microbial Peptides
- 1.3.4 Animal Anti-Microbial Peptides
- 1.3.5 Insects Anti-Microbial Peptides
- 1.4 Market Segment by Application
- 1.4.1 Global Anti Microbial Peptides Market Share by Application (2019-2025)
- 1.4.2 Personal Care and Cosmetics Industry
- 1.4.3 Healthcare & Pharmaceuticals Industry
- 1.4.4 Biotechnology Industry
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anti Microbial Peptides Market Size
- 2.1.1 Global Anti Microbial Peptides Revenue 2014-2025
- 2.1.2 Global Anti Microbial Peptides Sales 2014-2025
- 2.2 Anti Microbial Peptides Growth Rate by Regions
- 2.2.1 Global Anti Microbial Peptides Sales by Regions 2014-2019
- 2.2.2 Global Anti Microbial Peptides Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anti Microbial Peptides Sales by Manufacturers
- 3.1.1 Anti Microbial Peptides Sales by Manufacturers 2014-2019
- 3.1.2 Anti Microbial Peptides Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anti Microbial Peptides Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti Microbial Peptides Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anti Microbial Peptides Market Concentration Ratio (CR5 and HHI)
- 3.3 Anti Microbial Peptides Price by Manufacturers
- 3.4 Key Manufacturers Anti Microbial Peptides Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anti Microbial Peptides Market
- 3.6 Key Manufacturers Anti Microbial Peptides Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Plant Anti-Microbial Peptides Sales and Revenue (2014-2019)
- 4.1.2 Bacterial Anti-Microbial Peptides Sales and Revenue (2014-2019)
- 4.1.3 Animal Anti-Microbial Peptides Sales and Revenue (2014-2019)
- 4.1.4 Insects Anti-Microbial Peptides Sales and Revenue (2014-2019)
- 4.2 Global Anti Microbial Peptides Sales Market Share by Type
- 4.3 Global Anti Microbial Peptides Revenue Market Share by Type
- 4.4 Anti Microbial Peptides Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anti Microbial Peptides Sales by Application
6 United States
- 6.1 United States Anti Microbial Peptides Breakdown Data by Company
- 6.2 United States Anti Microbial Peptides Breakdown Data by Type
- 6.3 United States Anti Microbial Peptides Breakdown Data by Application
7 European Union
- 7.1 European Union Anti Microbial Peptides Breakdown Data by Company
- 7.2 European Union Anti Microbial Peptides Breakdown Data by Type
- 7.3 European Union Anti Microbial Peptides Breakdown Data by Application
8 China
- 8.1 China Anti Microbial Peptides Breakdown Data by Company
- 8.2 China Anti Microbial Peptides Breakdown Data by Type
- 8.3 China Anti Microbial Peptides Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anti Microbial Peptides Breakdown Data by Company
- 9.2 Rest of World Anti Microbial Peptides Breakdown Data by Type
- 9.3 Rest of World Anti Microbial Peptides Breakdown Data by Application
- 9.4 Rest of World Anti Microbial Peptides Breakdown Data by Countries
- 9.4.1 Rest of World Anti Microbial Peptides Sales by Countries
- 9.4.2 Rest of World Anti Microbial Peptides Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AnaSpec
- 10.1.1 AnaSpec Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.1.4 Anti Microbial Peptides Product Introduction
- 10.1.5 AnaSpec Recent Development
- 10.2 Novozymes
- 10.2.1 Novozymes Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.2.4 Anti Microbial Peptides Product Introduction
- 10.2.5 Novozymes Recent Development
- 10.3 Bachem
- 10.3.1 Bachem Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.3.4 Anti Microbial Peptides Product Introduction
- 10.3.5 Bachem Recent Development
- 10.4 Phoenix Biotech
- 10.4.1 Phoenix Biotech Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.4.4 Anti Microbial Peptides Product Introduction
- 10.4.5 Phoenix Biotech Recent Development
- 10.5 AMP Biotech
- 10.5.1 AMP Biotech Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.5.4 Anti Microbial Peptides Product Introduction
- 10.5.5 AMP Biotech Recent Development
- 10.6 Shanghai Abbiochem Company
- 10.6.1 Shanghai Abbiochem Company Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.6.4 Anti Microbial Peptides Product Introduction
- 10.6.5 Shanghai Abbiochem Company Recent Development
- 10.7 Ramamoorthy Group
- 10.7.1 Ramamoorthy Group Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.7.4 Anti Microbial Peptides Product Introduction
- 10.7.5 Ramamoorthy Group Recent Development
- 10.8 Lytix Biopharma
- 10.8.1 Lytix Biopharma Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.8.4 Anti Microbial Peptides Product Introduction
- 10.8.5 Lytix Biopharma Recent Development
- 10.9 Ai2
- 10.9.1 Ai2 Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Anti Microbial Peptides
- 10.9.4 Anti Microbial Peptides Product Introduction
- 10.9.5 Ai2 Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anti Microbial Peptides Sales Channels
- 11.2.2 Anti Microbial Peptides Distributors
- 11.3 Anti Microbial Peptides Customers
12 Market Forecast
- 12.1 Global Anti Microbial Peptides Sales and Revenue Forecast 2019-2025
- 12.2 Global Anti Microbial Peptides Sales Forecast by Type
- 12.3 Global Anti Microbial Peptides Sales Forecast by Application
- 12.4 Anti Microbial Peptides Forecast by Regions
- 12.4.1 Global Anti Microbial Peptides Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anti Microbial Peptides Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anti Microbial Peptides. Industry analysis & Market Report on Anti Microbial Peptides is a syndicated market report, published as Global (United States, European Union and China) Anti Microbial Peptides Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti Microbial Peptides market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
